US NewsDrugmaker Declines FDA Request to Pull Treatment After Patient DeathsSarepta stopped shipping Elevidys to non-ambulatory patients earlier this year.SavePrintThe U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch TimesZachary StieberSenior Reporter7/21/2025|Updated: 7/22/20250:00X 1Update: Sarepta is halting all shipments of Elevidys.Original story below.We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.